FDA chief looks to speed diabetes, obesity drugs
FDA chief looks to speed diabetes, obesity drugs Mark McClellan, commissioner of the Food and Drug Administration, said he wants to apply a fast-track review process normally reserved for drugs for terminal cancer and AIDS patients to drugs for diabetes and obesity.